Breaking News

TherapeutAix Expands R&D Network

Adds CROs Alderley Analytical and Peak Proteins to address Pharmacokinetics and Pharmacodynamics challenges for clients.

By: Contract Pharma

Contract Pharma Staff

TherapeutAix has added contract research organizations (CROs), Alderley Analytical and Peak Proteins to its global R&D network, forming a dedicated team to address Pharmacokinetics and Pharmacodynamics (PK/PD) challenges for clients. Based in Aachen, Germany, TherapeutAix is a biotech consultancy providing services from strategic planning to operationalization of studies. TherapeutAix has experience across multiple therapeutic areas, along with an integrated R&D network. Therapeu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters